Crowdfunding earned Eloise Mikkonen over a month’s salary

Submitted on Tue, 04/19/2016 - 10:05
Eloise Mikkonen
Eloise Mikkonen turned to international crowdfunding in order to find a solution to the frustrating lack of research funding. Photograph: Jonne Renvall

 

The crowdfunding campaign started by Eloise Mikkonen, a researcher investigating Alzheimer’s disease at the University of Tampere, has already produced good results. During the first week of her campaign, Mikkonen was able to gain the sum she had hoped for. In the first month, the total sum earned was GBP 2,755, which is over EUR 3,400.

“I was hoping it would be successful, but I wasn’t completely convinced the campaign would work so well,” Mikkonen says.

“I am currently funded until mid-June, which will hopefully allow me to perform some genome-wide analyses and finalise some manuscripts for publication on other projects I am involved in,” Mikkonen explains.

In the first month, 48 people participated in the crowdfunding campaign, mainly from Mikkonen’s native country Australia and her current home country Finland.

“I know the majority of the contributors, but there are also some very generous people who I do not know. There have also been contributors from the Netherlands, the United States, Denmark and the United Kingdom,” Mikkonen says.

The campaign, which started in early March, will end at the end of April.

In 2011, Mikkonen earned her doctorate at the University of Tampere. Her doctoral research showed that genes regulating the inflammatory response may affect the development of the neuropathological lesions associated with Alzheimer’s disease. They may thus participate in the initiation and progression of the disease.

She is now continuing her research with the brain collection data.

She has added new goals for the remainder of the crowdfunding campaign. For each one thousand pounds, i.e. about EUR 1,250, she will start analysing one new topic. There are five alternative areas to choose from, for example studying whether a person’s blood group plays a role in the occurrence of the lesions.

“Because of the data set I work with there are many options for studies. I have more ideas than I can or will have the time to do, so it will become the choice of those contributing to my research. I believe that any results from my studies will be important and significant for shedding light on how Alzheimer’s disease develops,” Mikkonen says.

Mikkonen’s campaign page on the Walacea platform

Alzheimer researcher at the University of Tampere is crowdfunding her research (News from the University of Tampere, 17 March 2016)